Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- PMID: 32203188
- PMCID: PMC7091858
- DOI: 10.1038/s41423-020-0402-2
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Conflict of interest statement
The authors declare no competing interests.
Figures

Comment in
-
NKG2A and COVID-19: another brick in the wall.Cell Mol Immunol. 2020 Jun;17(6):672-674. doi: 10.1038/s41423-020-0450-7. Epub 2020 May 7. Cell Mol Immunol. 2020. PMID: 32382127 Free PMC article. No abstract available.
Comment on
-
NKG2A is a NK cell exhaustion checkpoint for HCV persistence.Nat Commun. 2019 Apr 3;10(1):1507. doi: 10.1038/s41467-019-09212-y. Nat Commun. 2019. PMID: 30944315 Free PMC article.
Similar articles
-
NKG2A and COVID-19: another brick in the wall.Cell Mol Immunol. 2020 Jun;17(6):672-674. doi: 10.1038/s41423-020-0450-7. Epub 2020 May 7. Cell Mol Immunol. 2020. PMID: 32382127 Free PMC article. No abstract available.
-
Antiviral Drug Discovery To Address the COVID-19 Pandemic.mBio. 2020 Sep 25;11(5):e02134-20. doi: 10.1128/mBio.02134-20. mBio. 2020. PMID: 32978312 Free PMC article.
-
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.Epigenomics. 2020 May;12(10):811-812. doi: 10.2217/epi-2020-0154. Epub 2020 Jun 4. Epigenomics. 2020. PMID: 32495654 Free PMC article. No abstract available.
-
Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20932523. doi: 10.1177/2515690X20932523. J Evid Based Integr Med. 2020. PMID: 32551855 Free PMC article. Review.
-
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217. J R Coll Physicians Edinb. 2020. PMID: 32568289 Review. No abstract available.
Cited by
-
COVID-19 illness and autoimmune diseases: recent insights.Inflamm Res. 2021 Apr;70(4):407-428. doi: 10.1007/s00011-021-01446-1. Epub 2021 Feb 28. Inflamm Res. 2021. PMID: 33640999 Free PMC article. Review.
-
Immune checkpoint alterations and their blockade in COVID-19 patients.Blood Sci. 2022 Oct;4(4):192-198. doi: 10.1097/BS9.0000000000000132. Epub 2022 Aug 1. Blood Sci. 2022. PMID: 36311817 Free PMC article. Review.
-
SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level.Int J Med Sci. 2022 Oct 3;19(12):1787-1795. doi: 10.7150/ijms.73134. eCollection 2022. Int J Med Sci. 2022. PMID: 36313221 Free PMC article. Review.
-
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.Front Immunol. 2020 Jul 14;11:1660. doi: 10.3389/fimmu.2020.01660. eCollection 2020. Front Immunol. 2020. PMID: 32760407 Free PMC article. Review.
-
Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019.Crit Care Explor. 2020 Aug 10;2(8):e0178. doi: 10.1097/CCE.0000000000000178. eCollection 2020 Aug. Crit Care Explor. 2020. PMID: 32832913 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases